Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Distler

Showing results (61-70 of 350) with videos related to

Pageof 35
Sort By:
Expert Review of Clinical Immunology|July 28, 2011
Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?Astrid Jüngel, Jörg H W Distler, Steffen Gay, et al.
Geburtshilfe Und Frauenheilkunde|January 1, 1992
[Dexamethasone does not normalize disordered LH pulsatility in hyperandrogenemic ovarian insufficiency]M Graf, C Weiers, C Graf, et al.
Zentralblatt Fur Gynakologie|March 30, 1999
[Hyperthyroidism and acute renal failure in partial bladder mole]G Rönisch, G Kamin, S Haas, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|October 1, 1981
[Examination on maternal morbidity and mortality during delivery and puerperium (author's transl)]W Distler, H Albrecht, J Morgenstern, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|January 23, 2018
Targeting TGF-β signaling for the treatment of fibrosisAndrea Hermina Györfi, Alexandru-Emil Matei, Jörg H W Distler
Therapeutic Advances in Musculoskeletal Disease|February 21, 2022
The role of antifibrotics in the treatment of rheumatoid arthritis-associated interstitial lung diseaseMinrui Liang, Eric L Matteson, Andy Abril, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1990
[The value of functional tests in diagnosis of prolactinoma]W Klockenbusch, W Distler, M von Ditfurth, et al.
Rheumatology (Oxford, England)|September 17, 2008
Mechanisms of vascular damage in SSc--implications for vascular treatment strategiesS Guiducci, O Distler, J H W Distler, et al.
Clinical and Experimental Rheumatology|April 22, 2021
The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung diseaseLutz Wollin, Thuong Trinh-Minh, Yun Zhang, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Pageof 35

Showing results (61-70 of 350) with videos related to

Sort By:
Pageof 35
Expert Review of Clinical Immunology|July 28, 2011
Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?Astrid Jüngel, Jörg H W Distler, Steffen Gay, et al.
Geburtshilfe Und Frauenheilkunde|January 1, 1992
[Dexamethasone does not normalize disordered LH pulsatility in hyperandrogenemic ovarian insufficiency]M Graf, C Weiers, C Graf, et al.
Zentralblatt Fur Gynakologie|March 30, 1999
[Hyperthyroidism and acute renal failure in partial bladder mole]G Rönisch, G Kamin, S Haas, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|October 1, 1981
[Examination on maternal morbidity and mortality during delivery and puerperium (author's transl)]W Distler, H Albrecht, J Morgenstern, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|January 23, 2018
Targeting TGF-β signaling for the treatment of fibrosisAndrea Hermina Györfi, Alexandru-Emil Matei, Jörg H W Distler
Therapeutic Advances in Musculoskeletal Disease|February 21, 2022
The role of antifibrotics in the treatment of rheumatoid arthritis-associated interstitial lung diseaseMinrui Liang, Eric L Matteson, Andy Abril, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1990
[The value of functional tests in diagnosis of prolactinoma]W Klockenbusch, W Distler, M von Ditfurth, et al.
Rheumatology (Oxford, England)|September 17, 2008
Mechanisms of vascular damage in SSc--implications for vascular treatment strategiesS Guiducci, O Distler, J H W Distler, et al.
Clinical and Experimental Rheumatology|April 22, 2021
The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung diseaseLutz Wollin, Thuong Trinh-Minh, Yun Zhang, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Pageof 35